18 results
8-K
EX-3.1
UNCY
Unicycive Therapeutics Inc
14 Mar 24
Unicycive Announces $50 Million Private Placement
4:28pm
8-K
EX-3.6
UNCY
Unicycive Therapeutics Inc
14 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-3.4
UNCY
Unicycive Therapeutics Inc
14 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-3.1
UNCY
Unicycive Therapeutics Inc
14 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-3.3
UNCY
Unicycive Therapeutics Inc
14 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-3.2
kxaab
14 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-3.5
kxwz3ur94 d9
14 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-3.1
7x66022z
6 Mar 23
Unicycive Announces up to $130 Million Financing to Commercialize and Launch Investigational New Drug Renazorb
5:02pm
S-1/A
EX-3.3
1mdlierwc2mm
7 Jun 21
IPO registration (amended)
7:01am
S-1/A
EX-3.1
25jn559alu0god78et
7 Jun 21
IPO registration (amended)
7:01am
S-1/A
EX-3.2
dxrb29d6
7 Jun 21
IPO registration (amended)
7:01am
S-1
EX-3.4
kfx4c7p
21 May 21
IPO registration
4:07pm
S-1
EX-3.5
405in0
21 May 21
IPO registration
4:07pm
DRS/A
EX-3.1
51kkx76y
29 Apr 21
Draft registration statement (amended)
12:00am
DRS/A
EX-3.3
55jyu lmt5sgnb
29 Apr 21
Draft registration statement (amended)
12:00am
DRS/A
EX-3.2
5ylg 5ww91tkelu
29 Apr 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next